x

Evidence-Based Policy and Innovation Archive

Laura and John Arnold Foundation announces expanded funding for low-cost randomized controlled trials to drive effective social spending

Washington, D.C.—The Laura and John Arnold Foundation (LJAF) today announced additional funding for low- or modest-cost randomized controlled trials (RCTs) as part of its effort to expand the evidence base for “what works” in U.S. social spending. LJAF has committed to funding all proposals for RCTs of $100,000 to $300,000 that receive high ratings from … Read More

Laura and John Arnold Foundation announces request for criminal justice research proposals

NEW YORK, NY—The Laura and John Arnold Foundation (LJAF) today announced a request for criminal justice research proposals as part of its effort to build an evidence base about the approaches, innovations, and strategies that work best to improve public safety as well as fairness and efficiency in the criminal justice system. LJAF has committed … Read More

Laura and John Arnold Foundation awards research grants to study minimum wage increases

Houston, TX—Elected officials in a number of cities across the United States have approved increases to the local minimum wage in an effort to improve the well-being of low-income workers and families. In some communities, the minimum wage will increase by more than $5 an hour. Yet, not much is known about the impact of … Read More

Laura and John Arnold Foundation announces $7.4 million grant to support Government Performance Lab at Harvard University

Houston, TX—The Laura and John Arnold Foundation (LJAF) today announced a $7.4 million grant to the Harvard Kennedy School (HKS) to support the work of its Government Performance Lab (GPL).  Aimed at helping to improve the results governments achieve for their citizens, the lab is addressing a number of pressing social problems, including educational achievement … Read More

Why government needs more randomized controlled trials: Refuting the myths

The Laura and John Arnold Foundation (LJAF) today released a policy brief focused on the value and benefits of randomized controlled trials (RCTs). Such trials are widely recognized as the gold standard in scientific research. However, some critics have claimed that they are often expensive, time-consuming, unethical, or not worth the trouble. These objections are almost … Read More